The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats.
Soria
I
I
Zimmerman
C L
CL
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001262:Atenolol / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics; D001682:Biological Availability; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D007408:Intestinal Absorption; D010477:Perfusion; D051381:Rats; D013237:Stereoisomerism
D000319:Adrenergic beta-Antagonists; D000998:Antiviral Agents; D015224:Dideoxynucleosides; C057503:carbovir; D001262:Atenolol